"At the Minneapolis Heart Institute, we believe in treating more than just your heart. We support your body, mind and spirit while providing the best care to you and your loved ones. Services include: • Advanced Heart Failure Clinic • Cardiac Thoracic and Transplant Surgery • Cardiovascular consultations • Complex Heart Valve Disorder • Electrophysiology • Genetic Arrhythmia Center • HeartScan Minnesota • Licensed dietician • OPTIMIST • Preventative Cardiology Clinic • Pulmonary Hypertension Program • Vascular & endovascular services • Women’s heart health."

During the past decade, Minneapolis Heart Institute conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 18 clinical trials were completed, i.e. on average, 34% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 12 clinical trials were completed. i.e. 41.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Minneapolis Heart Institute" #1 sponsor was "Abbott Medical Devices" with 19 trials, followed by "Minneapolis Heart Institute Foundation" with 5 trials sponsored, "TransMedics" with 5 trials sponsored, "Edwards Lifesciences" with 3 trials sponsored and "Lisata Therapeutics, Inc." with 3 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Minneapolis Heart Institute" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Cardiovascular Research Foundation, New York" with 2 trials as a collaborator, "Clinical Trials in Organ Transplantation" with 2 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator and "Minneapolis Heart Institute" with 2 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Minneapolis Heart Institute" are "Coronary Artery Disease" (20 trials), "Heart Failure" (13 trials), "Angina Pectoris" (5 trials), "Heart Transplant" (5 trials) and "Myocardial Ischemia" (5 trials). Many other conditions were trialed in "Minneapolis Heart Institute" in a lesser frequency.

Most popular intervention types in "Minneapolis Heart Institute" are "Device" (53 trials), "Drug" (19 trials), "Biological" (12 trials), "Other" (7 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "OCS Heart System" (3 trials), "SAPIEN 3 THV" (2 trials), "Sham Procedure" (2 trials) and "ABT NG DES 48 EECSS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Minneapolis Heart Institute" are 99 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Minneapolis Heart Institute". undefined are not yet recruiting, 14 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 50 completed trials in Minneapolis Heart Institute, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Minneapolis Heart Institute, 6 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 43 trials that are defined as “Not Applicable".